EMMAUS MEDICAL
Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for an oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. The company is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. They are initially focusing our product development efforts on Sickle Cell Disease, a genetic disorder Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment. The company was founded in 2000 and is headquartered in Torrance, California, United States.
EMMAUS MEDICAL
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2000-01-01
Address:
Torrance, California, United States
Country:
United States
Website Url:
http://www.emmausmedical.com
Total Employee:
11+
Status:
Active
Contact:
(877)420-6493
Total Funding:
99.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Apache Amazon Google Apps For Business
Similar Organizations
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
Board_member
2011-08-01
Current Employees Featured
Charles Stark Senior Vice President of Research & Development @ Emmaus Medical
Senior Vice President of Research & Development
2013-11-01
Yasushi Nagasaki Senior Vice President of Finance @ Emmaus Medical
Senior Vice President of Finance
2011-01-01
Lan T. Tran Co-President, Chief Administrative Officer & Corporate Secretary @ Emmaus Medical
Co-President, Chief Administrative Officer & Corporate Secretary
2008-05-01
Yutaka Niihara Co-Founder, CEO & Chairman @ Emmaus Medical
Co-Founder, CEO & Chairman
2003-01-01
Henry A. McKinnell Chairman @ Emmaus Medical
Chairman
Willis C. Lee Chief Operating Officer @ Emmaus Medical
Chief Operating Officer
2011-04-01
Peter B Ludlum Management Consultant @ Emmaus Medical
Management Consultant
2017-06-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-07-23 | Mynd Analytics | Mynd Analytics acquired by Emmaus Medical | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Emmaus Medical
Agility Capital
Agility Capital investment in Debt Financing - Emmaus Medical
Official Site Inspections
http://www.emmausmedical.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.66 K
- Host name: 104.43.142.33
- IP address: 104.43.142.33
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Metro Code: 679
- Timezone: America/Chicago
- Postal: 50307
More informations about "Emmaus Medical"
Emmaus Medical - Crunchbase Company Profile
Organization. Emmaus Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Emmaus …See details»
Company Information :: Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease …See details»
Investor Relations :: Emmaus Life Sciences, Inc. (EMMA)
Nov 19, 2024 Company. Emmaus Life Sciences, Inc. 21250 Hawthorne Blvd. Suite 800 Torrance, CA 90503 T: 310-214-0065See details»
Emmaus Medical, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Emmaus Medical, Inc. of Torrance, CA. Get the latest business insights from Dun & Bradstreet.See details»
FAQ :: Emmaus Life Sciences, Inc. (EMMA) - ir.emmausmedical.com
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
Emmaus Medical - 2025 Company Profile - Tracxn
Mar 19, 2025 Emmaus Medical - Small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia. Acquired by Generex Biotechnology. Raised funding over …See details»
Contact Us - Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. 21250 Hawthorne Blvd. Suite 800 Torrance, CA 90503. info@emmausmedical.com. Office: 310-214-0065 Fax: 310-214-0075See details»
Mission - Emmaus Medical, Inc.
The mission of Emmaus Life Sciences is to improve the lives of people in need through the discovery, development and commercialization of innovative treatments and therapies.See details»
emmausmedical.com Reviews: Is this site a scam or legit?
After you read why we deemed emmausmedical.com a low-risk site, please tell us how you came across this platform in the comments.. Scam Detectors Most Trusted Websites in Online …See details»
Emmaus Medical Company Profile -Sales, Contacts, Competitors – …
Emmaus Medical is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 22 years.See details»
Emmaus’s Competitors, Revenue, Number of Employees, Funding …
Emmaus’s Profile, Revenue and Employees. Emmaus is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of orphan and …See details»
Emmaus Medical, Inc. - CAGE.report
Primary? Code NAICS Code's Description "Buy Green"? (1) Small? (2) 1 325412 Pharmaceutical Preparation Manufacturing YesSee details»
Emmaus Medical (M269WMVERVY4) - highergov.com
Emmaus Medical (UEI M269WMVERVY4, CAGE 4KN12) based in Torrance CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare …See details»
Emmaus Medical | VentureRadar
Similar Companies: bluebird bio USA Publicly Traded bluebird has industry-leading clinical and research programs for sickle cell disease, beta-thalassemia and cerebral …See details»
Dr. Henry A. McKinnell Jr., Former Pfizer CEO, Joins Emmaus …
May 19, 2010 Dr. McKinnell retired as Chairman and CEO of Pfizer Inc, the world's largest research-based pharmaceutical company, in 2006, after originally joining the company in …See details»
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Nov 19, 2024 Total operating expenses for the three months were $4.3 million compared to $4.8 million in the comparable period in 2023. The decrease was due primarily to a decrease in …See details»
Emmaus Life Sciences Provides Operational Updates
Torrance CA, June 2, 2020 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, provided today operational updates in advance of the filing of its 10-K for …See details»
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Dec 31, 2023 Torrance CA, November 19, 2024 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle …See details»